ロード中...
Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma
BACKGROUND: Improving outcomes of patients with glioblastoma (GBM) represents a significant challenge in neuro-oncology. We undertook a systematic review of key parameters of phase II and III trials in GBM to identify and quantify the impact of trial design on this phenomenon. METHODS: Studies betwe...
保存先:
| 出版年: | Neurooncol Adv |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850118/ https://ncbi.nlm.nih.gov/pubmed/33543145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa171 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|